The microbiological properties of a dicloxacillin-hetacillin combination.
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D003470:Culture Media; D004009:Dicloxacillin / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D004357:Drug Synergism; D004926:Escherichia coli / Q000201:enzymology; D004927:Escherichia coli Infections / Q000188:drug therapy; D007711:Klebsiella pneumoniae / Q000201:enzymology; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects / Q000201:enzymology; D065093:beta-Lactamase Inhibitors
D003470:Culture Media; D004338:Drug Combinations; D010406:Penicillins; D065093:beta-Lactamase Inhibitors; D004009:Dicloxacillin